Trial to Alleviate Malnutrition With Fortified Spread Given as a Food Supplement to Underweight Infants
Lungwena Child Nutrition Intervention Study-4, LCNI-4. A Single-centre Intervention Trial in Rural Malawi, Testing the Potency of RUTF Supplementation to Alleviate Moderate Malnutrition Among 6-17 Month Old Infants
1 other identifier
interventional
176
1 country
1
Brief Summary
This study tests the hypothesis that underweight 6-17-month old infants receiving fortified spread as a food supplement for 12 weeks grow better during the supplementation than infants who are provided with maize-soy flour supplement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Feb 2005
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 16, 2005
CompletedFirst Posted
Study publicly available on registry
August 17, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2005
CompletedMay 20, 2014
April 1, 2007
August 16, 2005
May 19, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight gain during the 12-week follow-up (in grams)
Secondary Outcomes (5)
Length gain during the study period (mm)
Tibial length gain during the study period (mm)
Change in blood haemoglobin concentration during the study period (g/l)
Change in serum ferritin concentration during the study period (µg/l)
Mean change in anthropometric indices (weight-for-age z-score [WAZ], weight-for-height z-score [WHZ] and height-for-age z-score [HAZ])
Interventions
Eligibility Criteria
You may qualify if:
- Signed informed consent from at least one guardian
- Ages 6.00 months to 14.99 months
- Weight-for-age \< -2 z-scores
- Availability during the period of the study
- Permanent resident of the area
You may not qualify if:
- WHZ \< -3 z-scores or presence of oedema
- History of peanut allergy
- Severe illness warranting hospital referral
- Concurrent participation in another clinical trial with intervention to the child
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tampere Universitylead
- Academy of Finlandcollaborator
- Foundation for Paediatric Research, Finlandcollaborator
Study Sites (1)
College of Medicine, University of Malawi
Mangochi, Mangochi District, Malawi
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Per Ashorn, MD, PhD
University of Tampere, Medical School
- PRINCIPAL INVESTIGATOR
Kenneth M Maleta, MBBS, PhD
Kamuzu University of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 16, 2005
First Posted
August 17, 2005
Study Start
February 1, 2005
Study Completion
September 1, 2005
Last Updated
May 20, 2014
Record last verified: 2007-04